Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jan 4:7:40037.
doi: 10.1038/srep40037.

HIV-1 Env associates with HLA-C free-chains at the cell membrane modulating viral infectivity

Affiliations

HIV-1 Env associates with HLA-C free-chains at the cell membrane modulating viral infectivity

Michela Serena et al. Sci Rep. .

Erratum in

Abstract

HLA-C has been demonstrated to associate with HIV-1 envelope glycoprotein (Env). Virions lacking HLA-C have reduced infectivity and increased susceptibility to neutralizing antibodies. Like all others MHC-I molecules, HLA-C requires β2-microglobulin (β2m) for appropriate folding and expression on the cell membrane but this association is weaker, thus generating HLA-C free-chains on the cell surface. In this study, we deepen the understanding of HLA-C and Env association by showing that HIV-1 specifically increases the amount of HLA-C free chains, not bound to β2m, on the membrane of infected cells. The association between Env and HLA-C takes place at the cell membrane requiring β2m to occur. We report that the enhanced infectivity conferred to HIV-1 by HLA-C specifically involves HLA-C free chain molecules that have been correctly assembled with β2m. HIV-1 Env-pseudotyped viruses produced in the absence of β2m are less infectious than those produced in the presence of β2m. We hypothesize that the conformation and surface expression of HLA-C molecules could be a discriminant for the association with Env. Binding stability to β2m may confer to HLA-C the ability to preferentially act either as a conventional immune-competent molecule or as an accessory molecule involved in HIV-1 infectivity.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Cytofluorimetric analysis of A3.01 and ACH-2 cell lines.
(a) Dashed line: negative control (secondary antibody fluorescence); thin line: unstimulated cells; thick line: cells stimulated with TNF-α for 24 h. 2G12, DT9 and L31 antibodies detect HIV-1 Env, HLA-C heterotrimers and HLA-C free chains at the cell membrane, respectively. Following TNF-α stimulation, ACH-2 cells express HIV-1 Env glycoprotein (2G12 antibody); HLA-C heterotrimers are upregulated in both cell types (DT9 antibody); HLA-C free chains are upregulated only in ACH-2 cells (L31 antibody). (b) : unstimulated A3.01 cells; : TNF-α stimulated A3.01 cells; : unstimulated ACH-2 cells; : TNF-α stimulated ACH-2 cells. Data from 6 independent experiments are shown as mean fluorescence intensity (MFI) of L31 staining. L31 fluorescence results to be significantly different between TNF-α stimulated ACH-2 cells (chronically infected by HIV-1) and A3.01 cells (parental cell line, uninfected) (p = 0.01), and between TNF-α stimulated and unstimulated ACH-2 cells (p = 0.002). p values were calculated by two-way ANOVA comparing ACH-2-TNF-α with A301-TNF-α and ACH-2-TNF-α with ACH-2-unstimulated.
Figure 2
Figure 2. Time course expression analysis of HIV-1 Env, MHC-I and β2m in TNF-α stimulated and unstimulated A3.01 and ACH-2 cells.
Cells were stained after 3, 24, 48 and 72 h of culture. Solid line: ACH-2 HIV-1 infected cells; dotted line: parental A3.01 cells. RFI (Relative Fluorescence Intensity) = (Mean Flourescence Intensity (MFI) sample − MFI control)/MFI control. Data are shown as fluorescence fold change between RFI of TNF-α stimulated and unstimulated cells. The presence of HLA-C free chains at the cell surface appears to be dependent on the presence of HIV-1 Env; expression of both Env and HLA-C free chains decreases at later times (48 and 72 h post TNF-α stimulation, panel 2G12 for Env and panel L31 for HLA-C free chains). No changes in the expression of total HLA-C (L31 AW panel, after an acid wash to remove β2m), HLA-C heterotrimers (DT9 panel), MHC-I (W6/32 panel) or β2m (NAMB-1 panel) are observed.
Figure 3
Figure 3. HIV-1 Env expression correlates with HLA-C free chains upregulation.
(a) Black line: negative control (secondary antibody fluorescence); blue line: PM1 unstimulated cells; red line: PM1 cells stimulated with TNF-α for 48 h. In the absence of stimulation, HIV-1 (IIIB strain) infection (2G12 staining) induces the downregulation of MHC-I molecules (W6/32 staining) and a slight increase of HLA-C free chains molecules at the cell surface (L31 staining), compared to the uninfected cells. After TNF-α stimulation, the HIV-1 replication is increased and the expression of MHC-I molecules at the cell membrane is restored. The increased HIV-1 Env expression correlates with a higher presence of HLA-C free chains molecules at the cell surface of the infected cells, compared to the uninfected ones. (b) Shaded curve: negative control (secondary antibody fluorescence); black line: 293T transfected with pcDNA3 (Mock); blue line: 293T transfected with pSG3Δenv; red line: 293T transfected with HIV-1 QHO-Env plasmid. L31 staining indicates an increase of HLA-C free chains at the cell membrane of cells transfected with HIV-1 Env, compared to the the transfection with pcDNA3 or pSG3Δenv plasmids. On the contrary, after acid wash (L31 AW) no differences in the amount of total HLA-C molecules were detected.
Figure 4
Figure 4. Cytofluorimetric analysis of β2m negative 293T cells, after transfection with different HIV-1 genes.
Shaded curve: negative control (secondary antibody fluorescence); red line: L31 labelled cells. After transfection with plasmids encoding different HIV-1 proteins, cells were labelled with the L31 antibody, after acid wash. As a positive control cells were transfected with β2m. Cytofluorimetric analyses indicate that only β2m transfection is able to restore HLA-C at the cell membrane of β2m negative cells. Neither the presence of Env, nor the presence of other HIV-1 proteins is sufficient to translocate HLA-C to the cell surface.
Figure 5
Figure 5. The presence of HLA-C free-chains at the cell membrane is dependent on β2m expression.
(a) L31 labelling, after acid wash, indicates that both HeLa and HeLa-Lai β2m negative cells (β2m−) are unable to express HLA-C molecules at the plasma membrane while the parental cell lines (β2m+) normally translocate HLA-C to the cell surface. The error bars represent standard errors from the mean calculated from quadruplicate determinations. (b) Shaded curve: negative control (secondary antibody fluorescence); dashed line: β2m− cells; solid line: β2m+ cells. HLA-C membrane expression is detected only in the parental β2m positive cells.
Figure 6
Figure 6. BiFC assay between Env and HLA-C in HeLa cells.
(a) Nuclear complementation between Jun-Yn and Fos-Yc was assessed as a positive control (green signal). (b) Complementation between Env-Yn and Fos-Yc was assessed as a negative control. (c,e) Transfection of Env-Yn and Env-Yc leads to the BiFC signal (green), indicating Env oligomerization at the cell membrane. (d,f) Transfection of Env-Yn and HLA-C-Yc leads to the BiFC signal (green) indicating the Env/HLA-C interaction at the cell membrane. In panels c and d β2m is labelled in red.
Figure 7
Figure 7. Env and HLA-C are associated at the cell surface.
(a) HeLa and HeLa-Lai cells were treated with the cell membrane insoluble DTSSP cross-linker. Proteins were purified on GN lectin columns by elution with increasing concentrations (from 0.25 to 1 M) of methyl α-D-mannopyranoside. Purified complexes heavier than 100 kDa were analysed by western blot. Env purification is evident in HeLa-Lai cells and not in control HeLa cells. HLA-C molecules, containing few mannoses, are eluted in the first fractions from HeLa cells, while they are co-purified in higher amounts in the presence of Env (HeLa-Lai). No differences in flotillin-1 purification, used as negative control, were detected. (b) Membrane protein complexes from HeLa and HeLa-Lai cells were immunoprecipitated with 2G12 (anti-Env), DT9 (anti-HLA-C) and a-β2m (anti-β2m) antibodies. Western blot analysis of immunoprecipitated samples shows that HLA-C is associated either with β2m or with Env. HLA-C and α/β-tubulin expression were detected as loading control.
Figure 8
Figure 8. Luciferase-based HIV-1 pseudoviruses infectivity assay on TZM-bl cells.
Pseudoviruses produced in parental 293 T β2m+ cells (solid line) are significantly more infectious than those produced in 293 T β2m− cells (dotted line). This is observed for two HIV-1 Env pseudotyped viruses (QHO and pRHPA) (p < 0.0001) and not for an unrelated pseudotyped virus (VSV-G). Data are expressed as Relative Luminescence Units (RLU). The error bars represent standard deviations from the mean calculated from quadruplicate determinations. p values were calculated by two-way ANOVA, comparing β2m+ and β2m− pseudoviruses.

Similar articles

Cited by

References

    1. Lakhashe S. K., Thakar M. R., Bharucha K. E. & Paranjape R. S. Quantitation of HLA proteins incorporated by human immunodeficiency virus type 1 and assessment of neutralizing activity of anti-HLA antibodies. J Virol 82, 428–434 (2008). - PMC - PubMed
    1. Esser M. T. et al. Differential incorporation of CD45, CD80 (B7-1), CD86 (B7-2), and major histocompatibility complex class I and II molecules into human immunodeficiency virus type 1 virions and microvesicles: implications for viral pathogenesis and immune regulation. J Virol 75, 6173–6182 (2001). - PMC - PubMed
    1. Cosma A. et al. Enhanced HIV infectivity and changes in GP120 conformation associated with viral incorporation of human leucocyte antigen class I molecules. Aids 13, 2033–2042 (1999). - PubMed
    1. Matucci A. et al. HLA-C increases HIV-1 infectivity and is associated with gp120. Retrovirology 5, 68 (2008). - PMC - PubMed
    1. Baroni M. et al. HLA-C is necessary for optimal human immunodeficiency virus type 1 infection of human peripheral blood CD4 lymphocytes. The Journal of general virology 91, 235–241 (2010). - PubMed

Publication types

Substances